TY - JOUR T1 - Is True Whole-Body <sup>18</sup>F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1087 LP - 1093 DO - 10.2967/jnumed.118.222299 VL - 60 IS - 8 AU - Juliano J. Cerci AU - Elba C. Etchebehere AU - Helen Nadel AU - Anita Brink AU - Chandrasekhar S. Bal AU - Venkatesh Rangarajan AU - Thomas Pfluger AU - Olga Kagna AU - Omar Alonso AU - Fatima K. Begum AU - Kahkashan Bashir Mir AU - Vincent P. Magboo AU - Leon J. Menezes AU - Diana Paez AU - Thomas N. Pascual Y1 - 2019/08/01 UR - http://jnm.snmjournals.org/content/60/8/1087.abstract N2 - Guidelines recommend true whole-body 18F-FDG PET/CT scans from vertex to toes in pediatric lymphoma patients, although this suggestion has not been validated in large clinical trials. The objective of the study was to evaluate the incidence and clinical impact of lesions outside the “eyes to thighs” regular field of view (R-FOV) in 18F-FDG PET/CT staging (sPET) and interim (iPET) scans in pediatric lymphoma patients. Methods: True whole-body sPET and iPET scans were prospectively obtained in pediatric lymphoma patients (11 worldwide centers). Expert panel central review of sPET and iPET scans were evaluated for lymphoma lesions outside the R-FOV and clinical relevance of these findings. Results: A total of 610 scans were obtained in 305 patients. The sPET scans did not show lesions outside the R-FOV in 91.8% of the patients, whereas in 8.2% patients the sPET scans demonstrated lesions also outside the R-FOV (soft tissue, bone, bone marrow, and skin); however, the presence of these lesions did not change the clinical stage of any patient and did not affect treatment decision. Among the 305 iPET scans, there were no new positive 18F-FDG–avid lesions outside the R-FOV, when compared with their paired sPET scans. A single lesion outside the R-FOV on iPET occurred in 1 patient (0.3%), with the primary lesion diagnosed in the femur on sPET that persisted on iPET. Conclusion: The identification of additional lesions outside the R-FOV (eyes to thighs) using 18F-FDG PET/CT has no impact in the definition of the clinical stage of disease and minimal impact in the treatment definition of patients with pediatric lymphoma. As so, R-FOV for both sPET and iPET scans could be performed. ER -